StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO)
Stock analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and issued a $10.00 target price on shares of Cytosorbents in a report […]
Stock analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, D. Boral Capital reiterated a “buy” rating and issued a $10.00 target price on shares of Cytosorbents in a report […]
